Stockreport

Ionis Pharma's danvatirsen shows positive effect in mid-stage head and neck cancer study; shares up 4% [Seeking Alpha]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Results from a Phase 1b/2 clinical trial evaluating Ionis Pharmaceuticals' ( IONS ) antisense drug danvatirsen (AZD9150), combined with AstraZeneca's ( AZN [Read more]